{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Impaired+Cognition&page=53", "query": { "condition": "Impaired Cognition", "page": 53 }, "page_size": 10 }, "pagination": { "page": 53, "page_size": 10, "total_count": 1884, "total_pages": 189, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Impaired+Cognition&page=54&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Impaired+Cognition&page=52&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-31T23:56:17.466Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03724136", "title": "Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Alzheimer Disease", "Alzheimer Dementia", "Vascular Dementia", "Lewy Body Disease", "Lewy Body Dementia With Behavioral Disturbance (Disorder)", "Dementia, Mixed", "Parkinson-Dementia Syndrome", "Chronic Traumatic Encephalopathy", "Huntington's Dementia", "Wernicke Korsakoff Syndrome", "Traumatic Brain Injury", "Dementia, Multi-Infarct", "Autism", "Autism Spectrum Disorder", "Autistic Behavior", "Autistic Disorder, Current or Active State", "Cadasil", "LATE Limbic-predominant Age-related TDP-43 Encephalopathy" ], "interventions": [ { "name": "Intravenous Bone Marrow Stem Cell (BMSC) Fraction", "type": "PROCEDURE" }, { "name": "Intranasal Topical Bone Marrow Stem Cell (BMSC) Fraction", "type": "PROCEDURE" }, { "name": "Near Infrared Light", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "MD Stem Cells", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2018-10-24", "completion_date": "2025-07-31", "has_results": false, "last_update_posted_date": "2024-04-15", "last_synced_at": "2026-10-31T23:56:17.466Z", "location_count": 2, "location_summary": "Westport, Connecticut • Coral Springs, Florida", "locations": [ { "city": "Westport", "state": "Connecticut" }, { "city": "Coral Springs", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03724136" }, { "nct_id": "NCT06501820", "title": "Neural Control of Gait & Navigation in ADRD", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Aging" ], "interventions": [ { "name": "Transcranial direct current stimulation", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": "89 Years", "sex": "ALL", "summary": "65 Years to 89 Years" }, "enrollment_count": 60, "start_date": "2025-11-13", "completion_date": "2030-05-01", "has_results": false, "last_update_posted_date": "2026-07-31", "last_synced_at": "2026-10-31T23:56:17.466Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06501820" }, { "nct_id": "NCT03016741", "title": "Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Castration-Resistant Prostatic Cancer", "Metastatic Prostate Carcinoma", "Recurrent Prostate Carcinoma", "Stage IV Prostate Cancer", "Hormone-Refractory Prostate Cancer" ], "interventions": [ { "name": "GnRH agonist/antagonist", "type": "BIOLOGICAL" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Abiraterone Acetate", "type": "DRUG" }, { "name": "Enzalutamide", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 100, "start_date": "2017-03-31", "completion_date": "2029-08", "has_results": false, "last_update_posted_date": "2026-02-24", "last_synced_at": "2026-10-31T23:56:17.466Z", "location_count": 5, "location_summary": "Los Angeles, California • Chicago, Illinois • New Orleans, Louisiana + 2 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT03016741" }, { "nct_id": "NCT05411822", "title": "Understanding Circadian Responses to Light in Persons With Mild Cognitive Impairment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Mild Cognitive Impairment", "Alzheimer Disease" ], "interventions": [ { "name": "Lighting Intervention Blue light", "type": "DEVICE" }, { "name": "Lighting Intervention Green light", "type": "DEVICE" }, { "name": "Dim-light control condition", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "Icahn School of Medicine at Mount Sinai", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "55 Years", "maximum_age": null, "sex": "ALL", "summary": "55 Years and older" }, "enrollment_count": 36, "start_date": "2021-06-14", "completion_date": "2024-05-31", "has_results": true, "last_update_posted_date": "2025-06-24", "last_synced_at": "2026-10-31T23:56:17.466Z", "location_count": 1, "location_summary": "Menands, New York", "locations": [ { "city": "Menands", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05411822" }, { "nct_id": "NCT03527472", "title": "Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lupus Erythematosus, Systemic" ], "interventions": [ { "name": "Memantine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 111, "start_date": "2018-08-23", "completion_date": "2026-02-28", "has_results": false, "last_update_posted_date": "2026-04-22", "last_synced_at": "2026-10-31T23:56:17.466Z", "location_count": 3, "location_summary": "Cleveland, Ohio • Nashville, Tennessee • Houston, Texas", "locations": [ { "city": "Cleveland", "state": "Ohio" }, { "city": "Nashville", "state": "Tennessee" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03527472" }, { "nct_id": "NCT00506415", "title": "Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Alzheimer Disease" ], "interventions": [ { "name": "Rivastigmine 5 cm^2", "type": "DRUG" }, { "name": "Rivastigmine 10 cm^2", "type": "DRUG" }, { "name": "Rivastigmine 15 cm^2", "type": "DRUG" }, { "name": "Placebo to 15 cm^2 patch", "type": "DRUG" }, { "name": "Placebo to 10 cm^2 patch", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "50 Years to 85 Years" }, "enrollment_count": 1584, "start_date": "2007-06", "completion_date": "2011-05", "has_results": true, "last_update_posted_date": "2012-09-19", "last_synced_at": "2026-10-31T23:56:17.466Z", "location_count": 65, "location_summary": "Birmingham, Alabama • Gilbert, Arizona • Phoenix, Arizona + 61 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00506415" }, { "nct_id": "NCT05215717", "title": "Hypnosis for Sleep Quality for Individuals With Mild Cognitive Impairment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Mild Cognitive Impairment", "Poor Quality Sleep" ], "interventions": [ { "name": "Self-Administered Hypnosis", "type": "BEHAVIORAL" }, { "name": "Self-Administered White Noise Hypnosis", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Baylor University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 23, "start_date": "2022-02-22", "completion_date": "2022-11-06", "has_results": false, "last_update_posted_date": "2024-03-13", "last_synced_at": "2026-10-31T23:56:17.466Z", "location_count": 1, "location_summary": "Waco, Texas", "locations": [ { "city": "Waco", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05215717" }, { "nct_id": "NCT06839079", "title": "Cognitive Rehabilitation for Victims of War and Related Traumas With Traumatic Brain Injury and Cognitive Impairment", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "TBI (Traumatic Brain Injury)", "Cognitive Symptoms" ], "interventions": [ { "name": "A Trauma-informed, Paraprofessional Delivered Virtual Cognitive Rehabilitation Program", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 50, "start_date": "2025-10-15", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-07-09", "last_synced_at": "2026-10-31T23:56:17.466Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06839079" }, { "nct_id": "NCT03682185", "title": "The Healthy Patterns Sleep Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Dementia", "Alzheimer Disease", "Circadian Rhythm Disorders", "Circadian Rhythm Sleep Disorder", "Insomnia", "Hypersomnia", "Cognitive Impairment", "Cognitive Decline", "Mild Cognitive Impairment", "Frontotemporal Dementia", "Neurocognitive Disorders", "Vascular Dementia", "Sleep Disorder", "Memory Impairment" ], "interventions": [ { "name": "Attention-Control Condition", "type": "BEHAVIORAL" }, { "name": "Timed Activity Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "110 Years", "sex": "ALL", "summary": "18 Years to 110 Years" }, "enrollment_count": 421, "start_date": "2016-05-01", "completion_date": "2021-05-31", "has_results": true, "last_update_posted_date": "2024-07-26", "last_synced_at": "2026-10-31T23:56:17.466Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03682185" }, { "nct_id": "NCT01956279", "title": "Complementary Neurosteroid Intervention in Gulf War Illnesses (GWVI)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Fatigue", "Musculoskeletal Pain", "Cognitive Decline" ], "interventions": [ { "name": "Pregnenolone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "40 Years to 65 Years" }, "enrollment_count": 170, "start_date": "2013-10-01", "completion_date": "2018-10-10", "has_results": true, "last_update_posted_date": "2020-05-01", "last_synced_at": "2026-10-31T23:56:17.466Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01956279" } ] }